isoxazoles has been researched along with Dyspepsia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheewakidakarn, J; Nimmaanrat, S; Siribumrungwong, K; Tangtrakulwanich, B | 1 |
| Eisen, GM; Goldstein, JL; Hanna, DB; Rublee, DA | 1 |
| Goldstein, JL; Mayne, TJ; Rabeneck, L; Rublee, DA; Vu, A | 1 |
| Bevirt, T; Makarowski, W; Recker, DP; Zhao, WW | 1 |
1 review(s) available for isoxazoles and Dyspepsia
| Article | Year |
|---|---|
Meta-analysis: upper gastrointestinal tolerability of valdecoxib, a cyclooxygenase-2-specific inhibitor, compared with nonspecific nonsteroidal anti-inflammatory drugs among patients with osteoarthritis and rheumatoid arthritis.
Topics: Abdominal Pain; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Cyclooxygenase Inhibitors; Dyspepsia; Female; Humans; Isoxazoles; Male; Middle Aged; Nausea; Osteoarthritis; Randomized Controlled Trials as Topic; Sulfonamides | 2005 |
3 trial(s) available for isoxazoles and Dyspepsia
| Article | Year |
|---|---|
Comparing parecoxib and ketorolac as preemptive analgesia in patients undergoing posterior lumbar spinal fusion: a prospective randomized double-blinded placebo-controlled trial.
Topics: Adult; Aged; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Dyspepsia; Female; Humans; Incidence; Injections, Intravenous; Isoxazoles; Ketorolac; Lumbar Vertebrae; Male; Middle Aged; Nausea; Pain, Postoperative; Prospective Studies; Spinal Fusion; Treatment Outcome | 2015 |
Valdecoxib is associated with improved dyspepsia-related health compared with nonspecific NSAIDs in patients with osteoarthritis or rheumatoid arthritis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cyclooxygenase Inhibitors; Diclofenac; Double-Blind Method; Dyspepsia; Female; Humans; Ibuprofen; Isoxazoles; Male; Middle Aged; Naproxen; Osteoarthritis; Pain Measurement; Patient Satisfaction; Placebos; Quality of Life; Sulfonamides; Treatment Outcome; Upper Gastrointestinal Tract | 2005 |
Efficacy and safety of the COX-2 specific inhibitor valdecoxib in the management of osteoarthritis of the hip: a randomized, double-blind, placebo-controlled comparison with naproxen.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Chi-Square Distribution; Constipation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Administration Schedule; Dyspepsia; Humans; Isoenzymes; Isoxazoles; Membrane Proteins; Middle Aged; Naproxen; Osteoarthritis, Hip; Prostaglandin-Endoperoxide Synthases; Sulfonamides | 2002 |